OLV Ziekenhuis

Aalst 9300

1 studies enrolling now · 12 studies all time

What they study most

Acute Decompensated Heart Failure, Chronic Kidney Failure, Coronary Artery Disease, Endometrial Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Gastric Cancer Third Line, Glomerulonephritis, Membranous, Hypertension, Hypertension, Essential, Hypertension, Systolic, Non-Small Cell Lung Cancer

Studies at this site

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT — Recruiting now
Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy. — Completed
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma — Running, not enrolling
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression — Completed
Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) — Completed
Cardionomic STOP-ADHF Study — Completed
Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300) — Completed
LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB) — Completed
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT — Completed
FFRangio Accuracy vs. Standard FFR — Completed
A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments — Completed
Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride — Stopped early